Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene

Farida Latif(Frederick National Laboratory for Cancer Research), Kálmán Tory(LabCorp (United States)), James R. Gnarra(National Institutes of Health), Masahiro Yao(Frederick National Laboratory for Cancer Research), Fuh-Mei Duh(LabCorp (United States)), Mary Lou Orcutt(Frederick National Laboratory for Cancer Research), Thomas Stackhouse(LabCorp (United States)), Igor Kuzmin(Frederick National Laboratory for Cancer Research), William S. Modi(LabCorp (United States)), L. Geil(LabCorp (United States)), Laura S. Schmidt(LabCorp (United States)), Fangwei Zhou(Frederick National Laboratory for Cancer Research), Hua Li(LabCorp (United States)), Ming Wei(LabCorp (United States)), Fan Chen(LabCorp (United States)), G.M. Glenn(Center for Cancer Research), Peter Choyke(National Institutes of Health Clinical Center), McClellan M. Walther(National Institutes of Health), Yongkai Weng(National Institutes of Health), Dah-Shuhn R. Duan(National Institutes of Health), Michael Dean(Genesis Laboratories), Damjan Glavač(LabCorp (United States)), Frances M. Richards(University of Cambridge), Paul A. Crossey(University of Cambridge), M.A. Ferguson‐Smith(University of Cambridge), Denis Le Paslier(Fondation Jean Dausset-CEPH), llya Chumakov(Fondation Jean Dausset-CEPH), Daniel Cohen(Fondation Jean Dausset-CEPH), A. Craig Chinault(Baylor College of Medicine), Eamonn R. Maher(University of Cambridge), W. Marston Linehan(National Institutes of Health), Berton Zbar(Frederick National Laboratory for Cancer Research), Michael I. Lerman(Frederick National Laboratory for Cancer Research)
Science
May 28, 1993
Cited by 3,000

Abstract

A gene discovered by positional cloning has been identified as the von Hippel-Lindau (VHL) disease tumor suppressor gene. A restriction fragment encompassing the gene showed rearrangements in 28 of 221 VHL kindreds. Eighteen of these rearrangements were due to deletions in the candidate gene, including three large nonoverlapping deletions. Intragenic mutations were detected in cell lines derived from VHL patients and from sporadic renal cell carcinomas. The VHL gene is evolutionarily conserved and encodes two widely expressed transcripts of approximately 6 and 6.5 kilobases. The partial sequence of the inferred gene product shows no homology to other proteins, except for an acidic repeat domain found in the procyclic surface membrane glycoprotein of Trypanosoma brucei.


Related Papers